Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × ganitumab × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Sarcoma 3 Sarcoma, Ewing 2 Ovarian Neoplasms 2 Insulin-Like Growth Factor I, Resistance To 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoid Tumor 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pleural Effusion, Malignant 1 Neuroendocrine Tumors 1 Neoplasms 1 Lymphoma 1 Lung Neoplasms 1 Jaundice 1 Gastrointestinal Neoplasms 1 Endocrine Gland Neoplasms 1 Colonic Neoplasms 1 Adenoma, Islet Cell 1 Adenocarcinoma 1

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡